Hosted by Sikich and Coupa, this webinar will discuss how an innovative biopharmaceutical company, Werewolf Therapeutics Life Sciences, successfully transformed its spend management processes by driving efficiencies, increasing savings, and implementing efficient and compliant systems on a scalable foundation for growth.
Over the last 12 months, the integrins industry has witnessed promising data and clinical updates: 7 Hills Pharma’s new study demonstrated integrin activation can bring the heat to cold melanoma tumors and received the FDA’s Fast Track and Orphan Drug designation Caladrius Biosciences and Cend Therapeutics presented their alpha-v integrins PhIb/IIa trial data in pancreatic, colorectal and appendiceal...
Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development. Given the sheer volume of studies in the pipeline, the need to administer high doses, the clinical holds placed on gene therapy trials, and regulatory bodies being increasingly stringent on the safety standards they require; it has never been more...
A one-time registration process is required to gain access to this event
2022 Wells Fargo Healthcare Conference September 7 - 9, 2022, Encore Boston Harbor , Everett, Massachusetts Conference Coordinator: Deirdre Gilfeather
Your Practical Guide to Planning & Running Patient-Centric Decentralized Clinical Trials (DCTs) We all know that decentralized clinical trials offer a plethora of advantages to trial participants and sponsors. What we don’t know is how to simplify regulatory understanding, streamline internal protocols, restructure recruitment processes, improve patient communication and address all the other operational challenges...
Join Biocom California and representatives from Fisher Scientific, Marsh McLennan Agency, PIMCO (a partner of RetirementDNA), and Cultura as they discuss the ways in which Diversity, Equity and Inclusion are prioritized and weaved into life science business practices at employee, management, and senior leadership levels. This webinar aims to provide awareness to life science companies...
Join the Philadelphia Business Journal for a morning of networking and enticing conversation as we explore what’s next for cell and gene therapy. A key component fueling the growth of the Philadelphia region’s life sciences sector is the proliferation of cell and gene therapy companies. That has resulted in new jobs, new construction, and major...
Hear from experts from the U.S. Patent and Trademark Office and the Food and Drug Administration about the intricacies biotech and medtech startups face when securing Intellectual Property (IP) rights from the USPTO and seeking regulatory approval from the FDA. Government officials and industry professionals will join the discussion by offering their views and highlighting...
The Biocom California Cell & Gene Therapy Committee brings together members working in the cell therapy and gene therapy space to share ideas and best practices, and gain common understanding of this important therapeutic field to drive innovation and manufacturing approaches forward. NOTE: Committees are open to Biocom California industry member companies actively engaged in...
Mobile Technologies in Clinical Trials was established in 2013. It is an annual one-day program that takes place the day before DPHARM and addresses the availability of mobile/digital tools to help reduce patient and site burden in clinical trials while more accurately diagnosing patients in clinical research. The conference is geared primarily for clinical trial...
Integrating Clinical Care + Clinical Research. Patient Access to Clinical Trials. Closing the gaps between clinical research and clinical care can lead to higher rates of clinical trial participation inside of a health system, better health outcomes, lower cost of care and more satisfied patients. CRAACO® is a unique opportunity for pharma, healthcare, patients, regulators, payors, CROs and Health...
